The content on SugarWiseLife.com is intended to support, not replace, the relationship between you and your healthcare provider
Others reach 2.4mg and find the side effects too burdensome, stepping back down to 1.7mg for a better balance between efficacy and tolerability
Key Takeaways Agonism Profile: Tirzepatide is a dual GLP-1/GIP agonist, while Retatrutide is a "triple agonist" targeting GLP-1, GIP, and Glucagon receptors
Consider which days you struggle most with food cravings or overeating
If you have moderate-to-severe obstructive sleep apnea and obesity, Zepbound may be worth considering
Initially used for Type 2 diabetes, semaglutide has recently gained significant popularity for its impressive weight-loss results